Decrease in the levels of anti-cyclic citrullinated peptide antibody in Japanese patients with rheumatoid arthritis who responded to anti-tumor necrosis factor-α

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Modern rheumatology 2010-10, Vol.20 (5), p.528-530
Hauptverfasser:	Onishi, Sachiko, Yoshio, Taku, Nagashima, Takao, Minota, Seiji
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Anti-cyclic citrullinated peptide antibody Anti-TNF agents Antibodies, Monoclonal, Murine-Derived - therapeutic use Antirheumatic Agents - therapeutic use Arthritis, Rheumatoid - blood Arthritis, Rheumatoid - drug therapy Arthritis, Rheumatoid - physiopathology Biomarkers - blood Drug Therapy, Combination Etanercept Health Status Humans IgG IgM rheumatoid factor Immunoglobulin G - blood Immunoglobulin G - therapeutic use Immunoglobulin M - blood Methotrexate - therapeutic use Middle Aged Peptides, Cyclic - immunology Receptors, Tumor Necrosis Factor - therapeutic use Rituximab Severity of Illness Index Treatment Outcome Tumor Necrosis Factor-alpha - antagonists & inhibitors Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!